1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
2 |
| Hold |
1 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 28.91K | 468.02% |
| Gross profit | -77.98K | 162.61% |
| Net profit | -4.72M | 53.36% |
| EBITDA | -6.52M | 37.54% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €27.93M |
Number of shares | 6.38M |
52-week high/low | €24.55 - €3.32 |
| Dividends | No |
Beta | 0.52 |
P/E ratio | -0.31 |
PEG ratio | 0.00 |
P/B ratio | 0.91 |
P/S ratio | 288.95 |
Company profile
| Name | PAVmed |
| CEO | Lishan Aklog |
| Employees | 41 |
Discover assets
Shareholders of PAVmed also invest in the following assets
